[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Virus in Italy, September 2019", "description": "Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy\n\nhttps://pubmed.ncbi.nlm.nih.gov/33176598/\n\nhttps://journals.sagepub.com/doi/10.1177/0300891620974755?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed&\n\nPresence of SARS-CoV-2 receptor-binding domain (RBD)-specific antibodies\n\nBlood samples of 959 asymptomatic individuals enrolled in a prospective lung cancer screening trial\n\nItaly's first two cases of COVID-19 disease\n\nJanuary 30, 2020, two tourists from China in Rome\n\nFirst laboratory-confirmed Italian COVID-19 case, Lombardy on February 20, 2020,\n\nSeptember 2019 to March 2020\n\nSARS-CoV-2 RBD-specific antibodies were detected in 111 of 959 (11.6%) individuals\n\nIgM and some IgG\n\nSeptember 2019,  23/111\n\nOctober,    27/111\n\nNovember,   26/111\n\nDecember,   11/111\n\nJanuary,    3/111\n\nFebruary,   21/111\n\nUnexpected very early circulation of SARS-CoV-2 among asymptomatic individuals in Italy\n\nAt least one SARS-CoV-2\u2013positive patient was detected in 13 regions\n\nIgM antibodies were detected in 97 (10.1%) patients\n\nIgG antibodies were found in 16 (1.7%)\n\nAll the patients were asymptomatic at the time of\nblood sample collection.\n\nFirst IgM detected 3rd September\n\n\nInfection more widespread than believed\n\nTherefore an overestimation of the mortality rate\n\nSince November to December 2019\n\nMany general practitioners began reporting severe respiratory symptoms in elderly\nand frail people\n\nAtypical bilateral bronchitis\n\n(? organising pneumonia)\n\nAttributed to aggressive forms of seasonal influenza.\n\nNational Library of Medicine\n\nhttps://pubmed.ncbi.nlm.nih.gov/32371096/\n\nParis, December 2019\n\nPatient hospitalized for hemoptysis\n\nStored nasopharyngeal swab confirmed the diagnosis of\n\nSARS-CoV-2 infection.\n\nHarvard Library, Since autumn 2019\n\nhttps://dash.harvard.edu/handle/1/42669767\n\nIncrease of hospital traffic in the Wuhan region\n\nSatellite imagery\n\nCOVID-19 symptoms\u2013related queries in search engines\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAntibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19\n\nhttps://www.nejm.org/doi/full/10.1056/NEJMc2103916?emp=marcom&utm_source=nejmlist&utm_medium=email&utm_campaign=aomev2&utm_content=version-c\n\nModerna mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) \n\nEfficacy 94% in phase 3 trials\n\nDurability of protection, 180 days after 2nd dose\n\nAntibody activity remained high in all age groups at day 209\n\nResults are consistent with convalescent patients with Covid-19 through 8 months after symptom onset \n\nSupport the use of this vaccine in addressing the Covid-19 pandemic.", "link": "https://www.youtube.com/watch?v=i195K2vYfnY", "date_published": "2021-05-02 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Dr Nair, India, Summary", "description": "How is the situation in India now, are you seeing a lot of cases?\n\nHow is the death rate, are there a lot of deaths, now and in the past weeks?\n\nWhat is the causes of deaths in COVID patients, is it mostly respiratory failure?\n\nHave you had difficulties with supplies of oxygen and drugs?\n\nWhat are the local drivers of infection, are people flowing mask wearing and social distancing?\n\nAre you able to test all of the patients you suspect have COVID?\n\nHow are you treating patients with mild and more severe disease?\n\nWhat drugs do you use in addition to steroids?\n\nIs ivermectin effective to treat COVID?\n\nDo many patients develop secondary bacterial infection after COVID?\n\nDo you think many people might develop long covid with longer term sequala?", "link": "https://www.youtube.com/watch?v=YQdKsLZjmaQ", "date_published": "2021-05-01 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Dr Nair, Infectious Diseases Consultant, India", "description": "How is the situation in India now, are you seeing a lot of cases?\n\nHow is the death rate, are there a lot of deaths, now and in the past weeks?\n\nWhat is the causes of deaths in COVID patients, is it mostly respiratory failure?\n\nHave you had difficulties with supplies of oxygen and drugs?\n\nWhat are the local drivers of infection, are people flowing mask wearing and social distancing?\n\nAre you able to test all of the patients you suspect have COVID?\n\nHow are you treating patients with mild and more severe disease?\n\nWhat drugs do you use in addition to steroids?\n\nIs ivermectin effective to treat COVID?\n\nDo many patients develop secondary bacterial infection after COVID?\n\nDo you think many people might develop long covid with longer term sequala?", "link": "https://www.youtube.com/watch?v=Hd96VTr5TDw", "date_published": "2021-05-01 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Two vaccine shots, implications", "description": "Vary greatly on the two sides of the pond. US goes one way, the UK another.\nUK, awaiting rule change for 2 dosers\n\nhttps://www.bbc.co.uk/news/health-56929483\n\nIndoor gatherings\n\nWales, 3rd May\n\nEngland, Scotland 17th May\n\nNI, 24th May\n\nProf Jonathan Van-Tam\n\nIf two people who both had two doses of vaccine, \n\nand have both served at least 14 days after their second dose, \n\nthen I would be highly confident scientifically that if they were reputable vaccines then \nindeed it would be incredibly safe for those two people to meet\n\nPaul Hunter, Professor of Medicine, University of East Anglia\n\nTrue just now with B117\n\nThe issue is variants with escape mutations that are less affected by the vaccine, \nand we haven't come to clear understanding of what those risks are\n\nUK, Indian or South African variants yet to make an impact\n\nhttps://covid.joinzoe.com/post/indian-or-south-african-variants-yet-to-make-an-impact\n\n22nd April\n\nIndia\nhttps://www.aljazeera.com/news/2021/5/1/fire-in-hospitals-intensive-care-kills-18-in-indias-gujarat\n\nhttps://www.washingtonpost.com/nation/2021/04/29/coronavirus-covid-live-updates-us/\n\nCases, + 379,257 + 386,452 + 401,993 = 19,100,000\n\nDeaths, + 3,645 + 3,523 = 211,853\n\nVaccinations\n\nAll adults now eligible\n\nWas over 45s\n\nOne dose, 10%\n\nTwo doses 1.5%\n\nIndia / Australia\n\nCriminal offence for citizens to return home, from Monday\n\nIndia / US\n\nRestrictions from 4th May\n\nMost non-US citizens, India within the last 14 days will not be allowed into US\n\nIndia / France\n\nFirst case was detected in Lot-et Garonne, in southwestern France\n\nThe patient is currently hospitalised in Bordeaux\n\nhttps://www.lexpress.fr/actualite/societe/sante/ce-que-l-on-sait-des-differents-cas-de-variants-indiens-detectes-en-france_2149875.html\n\nTwo more cases in the south east \u2013 in the Marseille d\u00e9partement of Bouches-du-Rh\u00f4ne.\n\nTwo people returning from India without any link to one another\n\n10-day quarantine for arrivals from India, Brazil, South Africa, Chile and Argentina\n\nhttps://www.thelocal.fr/20210430/three-cases-of-the-indian-variant-of-covid-detected-in-france/?utm_source=piano&utm_medium=email&utm_campaign=213&tpcc=newsletter_members&pnespid=1fBz_aVRDRWNUoF70GTcVJXtQlLxVSWUNbDvEHY\n\nSequencing rate\n\nhttps://www.washingtonpost.com/nation/2021/04/29/coronavirus-covid-live-updates-us/#link-UVLBM3S2DFH65KGAD5772HMJ6Q\n\nIceland, 78.8%\n\nAustralia, 60.3%\n\nNew Zealand, 48.5%\n\nDenmark, 20.2%\n\nTaiwan, 16%\n\nUK, 8.7%\n\nNorway, 5.6%\n\nVietnam, 5.5%\n\nUS, 1%\n\nIndia (102) 18,000,000 (10,626) 0.06%\n\nU.S. government, $100 million worth of supplies\n\nUS State Department, U.S. citizens to leave India as soon as it is safe to do\n\nhttps://in.usembassy.gov/health-alert/\n\nSpread from cities to small towns\n\nhttps://www.bbc.co.uk/news/world-asia-india-56913047\n\nSpread now occurring, but underreported\n\nCorruption and black markets\n\nMedical debt already a big problem in India\n\nRemdesivir problem\n\nhttps://bnf.nice.org.uk/medicinal-forms/remdesivir.html\n\nRemdesivir for the Treatment of Covid-19 \u2014 Final Report (NEJM, 5th November 2020)\n\nhttps://www.nejm.org/doi/full/10.1056/nejmoa2007764\n\nDouble-blind, randomized, placebo-controlled trial of intravenous remdesivir\n\nTen day course\n\nHospitalized with Covid-19 with evidence of lower respiratory tract infection\n\nN = 1062\n\nRemdesivir group, 541\n\nPlacebo, 521\n\nRemdesivir group, n = 541\n\nMedian recovery time, 10 days\n\nNeed for oxygen, 13 days\n\nMortality by day 15 was 6.7%\n\nMortality by day 29 was 11.4%\n\nPlacebo controls, n = 521\n\nMedian recovery time 15 days\n\nNeed for oxygen, 21 days\n\nMortality by day 15 was 11.9%\n\nMortality by day 29 was 15.2% (HR = 0.73)\n\nSerious adverse events\n\nRemdesivir group, 24.6%\n\nPlacebo group, 31.6%\n\nSerious adverse events in placebo group, 31.6%", "link": "https://www.youtube.com/watch?v=hVo0pVC9Swk", "date_published": "2021-05-01 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]